Fosun Pharma, TPG make China healthcare move

Take-private bid for Chindex offers US private equity group exposure to China's burgeoning healthcare sector.

Fosun Pharma, TPG make China healthcare move

Shanghai Fosun Pharmaceutical Fosun Pharma and US private equity firm TPG have made an offer to take Nasdaq-listed healthcare company Chindex private in a $369 million deal.

The move offers TPG the chance to gain exposure to China's growing healthcare sector, an area that the government has been loosening restrictions on.

It also will enable the Chinese group’s management to partner two deep-pocketed players in its expansion drive.


To continue reading, please login or register for free

Click for more on: fosun pharma | tpg | chindex

Print Edition

FinanceAsia Print Edition


  • 2nd Compliance Summit Southeast Asia

    17 August 2017  |  Singapore
    The 2017 Compliance Summit Southeast Asia will take an in-depth look at the key compliance considerations today with a focus on regulation and new ...